Ultrathin strut stent for patients on blood thinners

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study focuses on patients who are on chronic oral anticoagulation and require percutaneous coronary revascularization with stent implantation. It evaluates the use of a new generation ultrathin strut sirolimus-eluting stent with a bioabsorbable polymer, which may allow for shorter antiplatelet therapy regimens. The study aims to assess the safety and efficacy of this stent in high-bleeding risk patients, potentially improving their treatment outcomes.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Patients must meet all inclusion criteria:

* Patients with Signed informed consent and
* Patients with \>=18 years old and
* Patients with chronically receiving oral anticoagulation treatment with any type of anticoagulant for any reason and
* Patients with de novo Coronary artery disease requiring both elective or urgent percutaneous revascularization due to stable coronary artery disease or acute coronary syndrome with or without ST-segment elevation, and in which an ultrathin strut Sirolimus-eluting stent with bioabsorbable polymer has been used

Exclusion Criteria:

Patients do not have to meet any exclusion criteria

* Patients treated percutaneously with any type of stent other than the SupraFlex Cruz® in the 6 months prior to the index procedure in which he or she is included.
* Use in the same procedure or in a scheduled procedure of other stents different from the one evaluated for the treatment of another vessel(s).
* Patients treatment for restenosis or stent thrombosis.
* Patients presentation in cardiogenic shock or after cardiorespiratory arrest.
* Patients with allergy to any of the components of the stent to be used.
* Patients with impossibility for follow-up.
* Patients with life expectancy less than 1 year.

Where it's running

• Hospital General Universitario de Albacete
  Albacete, Spain Recruiting
• Hospital Universitario San Juan de Alicante
  Alicante, Spain Recruiting
• Hospital General Universitario de Merida
  Badajoz, Spain Recruiting
• Hospital General Universitari de Castelló
  Castelló, Spain Recruiting
• H.G.U. de Ciudad Real.
  Ciudad Real, Spain Recruiting
• Hospital General Universitari d'Elx
  Elche, Spain Recruiting

Study contacts

• Study coordinator: Juan Gabriel Córdoba Soriano, MD, PhD
• Email: jgcordoba@foroepic.org
• Phone: 0034 967597532

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• QFR-guided virtual stenting to optimize PCI before the procedure

  We’re testing whether using QFR-based virtual stenting before PCI can improve heart-procedure outcomes compared with standard angiography planning in adults with coronary artery disease.

  Recruiting China National Center for Cardiovascular Diseases · Beijing, Beijing Municipality · NCT07635407

• LONG NAGOMI PMCF: follow-up of the Ultimaster Nagomi stent in long coronary artery lesions

  This project tests the Ultimaster Nagomi drug-eluting stent in adults undergoing PCI for long coronary lesions to collect real-world safety and effectiveness data.

  Recruiting at 10 sites Fundación EPIC · Cabueñes and 9 other locations · NCT07399002

• Coronary CT angiography versus standard follow-up after stent placement for high-risk patients

  This trial will test whether using coronary CT angiography instead of usual follow-up care helps people at high risk after stent placement stay healthier.

  Recruiting at 2 sites Samsung Medical Center · Bucheon-si and 21 other locations · NCT07009418

• Essential Pro paclitaxel‑eluting coronary balloon post-market follow-up (rEPIC04E-HK)

  This project will follow people with coronary artery disease treated with the Essential Pro paclitaxel‑eluting coronary balloon to see if the device is safe and works well in routine care.

  Recruiting Fundación EPIC · Lai Chi Kok · NCT06631157

• Investigating different doses of adenosine for heart imaging

  This study tests whether different doses of adenosine can improve heart imaging for people suspected of having chronic coronary syndrome.

  Recruiting Phase 4 Region Skane · Lund · NCT06578234

• Comparing enteric-coated and plain aspirin to reduce heart disease risks from air pollution

  This study is testing whether enteric-coated or plain low-dose aspirin can better help people with heart disease reduce their risks from air pollution, along with providing tips to stay healthy.

  Recruiting Rajaie Cardiovascular Medical and Research Center · Tehran, Tehran Province · NCT06541691

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.